ask="1.62"
ask_size="1000"
average_daily_volume="327255"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="+0.05"
change_from_200_day_moving_average="-0.14"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-3.52"
change_From_52_week_low="0.47"
change_in_percent="+3.08%"
close="1.58"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3761000"
high="1.62"
high_52_weeks="5.10"
last_trade_date="2/1/2017"
last_trade_price="1.58"
last_trade_size="985"
last_trade_time="4:00pm"
low="1.53"
low_52_weeks="1.11"
market_capitalization="15.14M"
moving_average_200_day="1.72"
moving_average_50_day="1.65"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="1.53"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.34%"
percent_change_from_50_day_moving_average="-4.11%"
percent_change_from_52_week_high="-69.02%"
percent_change_from_52_week_low="+42.34%"
previous_close="1.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.52"
price_per_sales="28.87"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="2.32"
stock_exchange="NCM"
symbol="EYEG"
volume="208465"
weeks_range_52="1.11 - 5.10"
